These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12837970)

  • 1. Pitavastatin inhibits upregulation of intermediate conductance calcium-activated potassium channels and coronary arteriolar remodeling induced by long-term blockade of nitric oxide synthesis.
    Terata Y; Saito T; Fujiwara Y; Hasegawa H; Miura H; Watanabe H; Chiba Y; Kibira S; Miura M
    Pharmacology; 2003 Aug; 68(4):169-76. PubMed ID: 12837970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of augmented expression of intermediate-conductance Ca2+-activated K+ channels in postischaemic heart.
    Saito T; Fujiwara Y; Fujiwara R; Hasegawa H; Kibira S; Miura H; Miura M
    Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):324-9. PubMed ID: 11985544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
    Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution of L-arginine-derived nitric oxide to the structural integrity of coronary artery and cardiac interstitium, and to the regulation of sympathetic nerve activity: assessment using a rat model produced by chronic nitric oxide inhibition].
    Nakamura T
    Hokkaido Igaku Zasshi; 1997 Sep; 72(5):503-16. PubMed ID: 9363467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
    Ni W; Egashira K; Kataoka C; Kitamoto S; Koyanagi M; Inoue S; Takeshita A
    Circ Res; 2001 Aug; 89(5):415-21. PubMed ID: 11532902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions.
    Egashira K; Ni W; Inoue S; Kataoka C; Kitamoto S; Koyanagi M; Takeshita A
    Hypertens Res; 2000 Jul; 23(4):353-8. PubMed ID: 10912772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats.
    Hsieh NK; Wang JY; Liu JC; Wang SD; Chen HI
    Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):212-8. PubMed ID: 15053816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
    J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats.
    Kitamoto S; Egashira K; Kataoka C; Koyanagi M; Katoh M; Shimokawa H; Morishita R; Kaneda Y; Sueishi K; Takeshita A
    Circulation; 2000 Aug; 102(7):806-12. PubMed ID: 10942751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Rho-kinase in vascular remodeling caused by long-term inhibition of nitric oxide synthesis in rats.
    Ikegaki I; Hattori T; Yamaguchi T; Sasaki Y; Satoh SI; Asano T; Shimokawa H
    Eur J Pharmacol; 2001 Sep; 427(1):69-75. PubMed ID: 11553365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels.
    Tomita H; Egashira K; Kubo-Inoue M; Usui M; Koyanagi M; Shimokawa H; Takeya M; Yoshimura T; Takeshita A
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1456-64. PubMed ID: 9743235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis.
    Koyanagi M; Egashira K; Kitamoto S; Ni W; Shimokawa H; Takeya M; Yoshimura T; Takeshita A
    Circulation; 2000 Oct; 102(18):2243-8. PubMed ID: 11056100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
    Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
    J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-hydroxytryptamine has an endothelium-derived hyperpolarizing factor-like effect on coronary flow in isolated rat hearts.
    Chien CC; Su MJ
    J Biomed Sci; 2015 Jun; 22(1):42. PubMed ID: 26076928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
    Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
    J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.